Compare NNNN & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | CNMD |
|---|---|---|
| Founded | 2021 | 1970 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2025 | 1987 |
| Metric | NNNN | CNMD |
|---|---|---|
| Price | $25.65 | $41.52 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $51.20 |
| AVG Volume (30 Days) | 73.0K | ★ 665.3K |
| Earning Date | 04-28-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 1.48% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.06 | ★ 1.51 |
| Revenue | $6,920,153.00 | ★ $1,374,724,000.00 |
| Revenue This Year | N/A | $2.49 |
| Revenue Next Year | N/A | $4.90 |
| P/E Ratio | $410.25 | ★ $26.93 |
| Revenue Growth | N/A | ★ 5.18 |
| 52 Week Low | $5.18 | $35.37 |
| 52 Week High | $55.65 | $74.70 |
| Indicator | NNNN | CNMD |
|---|---|---|
| Relative Strength Index (RSI) | 44.80 | 51.13 |
| Support Level | $22.10 | $35.37 |
| Resistance Level | $34.00 | $41.05 |
| Average True Range (ATR) | 6.84 | 1.63 |
| MACD | -0.40 | 0.04 |
| Stochastic Oscillator | 22.21 | 75.21 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.